Comparative Pharmacology
Head-to-head clinical analysis: NEO CORT DOME versus NEO DELTA CORTEF.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NEO CORT DOME versus NEO DELTA CORTEF.
NEO-CORT-DOME vs NEO-DELTA-CORTEF
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Neomycin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. Hydrocortisone is a corticosteroid that exerts anti-inflammatory and immunosuppressive effects by binding to glucocorticoid receptors and modulating gene expression.
Corticosteroid with potent anti-inflammatory, immunosuppressive, and antiallergic effects. Binds to glucocorticoid receptors, modulating gene expression to inhibit phospholipase A2, reduce prostaglandin and leukotriene synthesis, and suppress cytokine production.
Apply topically to affected area twice daily.
1-2 drops into the conjunctival sac every 1-2 hours during the day and every 2 hours at night initially, then reduce frequency as inflammation subsides.
None Documented
None Documented
2–3 hours (terminal elimination half-life of hydrocortisone); clinically, duration of action is longer due to intracellular receptor binding.
Prednisolone: 2-4 hours; clinical context: adrenal suppression lasts 24-36 hours, requiring tapering
Renal excretion of hydrocortisone metabolites (primarily conjugated as glucuronides and sulfates) accounts for >90% of elimination; <5% biliary/fecal.
Renal: 70-80% as metabolites; biliary: 10-15%; fecal: <5%
Category C
Category C
Corticosteroid with Antibiotic
Corticosteroid with Antibiotic